Literature DB >> 31136988

miR-21 regulates growth and EMT in lung cancer cells via PTEN/Akt/GSK3β signaling.

Lihua Dai1, Fenghua Chen2, Yonghua Zheng3, Ding Zhang4, Bao Qian3, Huaxia Ji3, Feng Long4, Dragos Cretoiu5.   

Abstract

miRNA-21 (miR-21) is overexpressed in various human cancers. Here, we show that miR-21 is overexpressed in human Non-Small Cell Lung Cancer (NSCLC)  and that its up or down-regulation, respectively, increases or decreases cyclin D1 and cyclin E1 expression and coordinately promotes or inhibits proliferation of cancer cells. The perturbations of miR-21 also dramatically reduces or increases epithelial to mesenschymal transition (EMT). We show that regulation of proliferation and EMT are directed by PTEN/Akt/GSK3 beta signaling axis by regulating the expression of invasion markers including E-cadherin, vimentin, snail, slug and beta-catenin. Together, these findings show that miR-21 is a potential target for the development of treatment for NSCLC forms of human lung cancer.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31136988     DOI: 10.2741/4788

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  20 in total

1.  MicroRNA-21 promotes epithelial-mesenchymal transition and migration of human bronchial epithelial cells by targeting poly (ADP-ribose) polymerase-1 and activating PI3K/AKT signaling.

Authors:  Shiqing Zhang; Peng Sun; Xinru Xiao; Yujie Hu; Yan Qian; Qian Zhang
Journal:  Korean J Physiol Pharmacol       Date:  2022-07-01       Impact factor: 1.718

Review 2.  Epithelial-mesenchymal transition: Insights into nickel-induced lung diseases.

Authors:  Hyun-Wook Lee; Cynthia C Jose; Suresh Cuddapah
Journal:  Semin Cancer Biol       Date:  2021-05-29       Impact factor: 15.707

Review 3.  Targeting Akt-associated microRNAs for cancer therapeutics.

Authors:  Mir S Adil; Daulat Khulood; Payaningal R Somanath
Journal:  Biochem Pharmacol       Date:  2020-12-24       Impact factor: 6.100

4.  Pitavastatin induces apoptosis in oral squamous cell carcinoma through activation of FOXO3a.

Authors:  Naeun Lee; Nirmala Tilija Pun; Won-Jun Jang; Jung Woo Bae; Chul-Ho Jeong
Journal:  J Cell Mol Med       Date:  2020-05-14       Impact factor: 5.310

5.  Sinomenine Inhibits Migration and Invasion of Human Lung Cancer Cell through Downregulating Expression of miR-21 and MMPs.

Authors:  Kun-Hung Shen; Jui-Hsiang Hung; Yi-Ching Liao; Shu-Ting Tsai; Ming-Jiuan Wu; Pin-Shern Chen
Journal:  Int J Mol Sci       Date:  2020-04-27       Impact factor: 5.923

Review 6.  Tackle Epithelial-Mesenchymal Transition With Epigenetic Drugs in Cancer.

Authors:  Bo Dong; Zhaoping Qiu; Yadi Wu
Journal:  Front Pharmacol       Date:  2020-11-27       Impact factor: 5.810

Review 7.  Small in Size, but Large in Action: microRNAs as Potential Modulators of PTEN in Breast and Lung Cancers.

Authors:  Asal Jalal Abadi; Ali Zarrabi; Mohammad Hossein Gholami; Sepideh Mirzaei; Farid Hashemi; Amirhossein Zabolian; Maliheh Entezari; Kiavash Hushmandi; Milad Ashrafizadeh; Haroon Khan; Alan Prem Kumar
Journal:  Biomolecules       Date:  2021-02-18

8.  MiR-21 Is Required for the Epithelial-Mesenchymal Transition in MDA-MB-231 Breast Cancer Cells.

Authors:  Elif Damla Arisan; Ozge Rencuzogullari; Clara Cieza-Borrella; Francesc Miralles Arenas; Miriam Dwek; Sigrun Lange; Pinar Uysal-Onganer
Journal:  Int J Mol Sci       Date:  2021-02-04       Impact factor: 5.923

9.  Lung Cancer Cells Derived Circulating miR-21 Promotes Differentiation of Monocytes into Osteoclasts.

Authors:  Qian Zhao; Chang Liu; Ying Xie; Mengjia Tang; Guojing Luo; Xiang Chen; Li Tian; Xijie Yu
Journal:  Onco Targets Ther       Date:  2020-03-31       Impact factor: 4.147

10.  The diagnostic role of microRNA 21 in patients with nonsmall cell lung cancer: An exploratory study.

Authors:  Shreyash Rai; Pankaj Kumar Garg; Shuchi Bhatt; Thammineni Krishna Latha; Amit Kumar Verma; Basu Dev Banerjee; Mahendra Pal Singh
Journal:  Lung India       Date:  2020 Nov-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.